Related Experiment Video

Updated: Jun 19, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Musings on genome medicine: Crohn's disease

David G Nathan1, Stuart H Orkin

  • 1Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

Genome Medicine
|November 7, 2009
PubMed

Insights

Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, present complex challenges for medical specialists and significantly impact patients and their families.

Area of Science:

  • Gastroenterology
  • Immunology
  • Genetics

Background:

  • Inflammatory bowel diseases (IBD), encompassing Crohn's disease and ulcerative colitis, represent a significant clinical challenge.
  • IBD affects a wide range of medical specialties, including gastroenterology, infectious diseases, immunology, and genetics.
  • These conditions impose a substantial burden on patients and their families.

Purpose of the Study:

  • To explore the multifaceted challenges posed by inflammatory bowel diseases.
  • To understand the impact of Crohn's disease and ulcerative colitis on patients and their families.

Main Methods:

  • Review of existing literature on inflammatory bowel diseases.
  • Analysis of the interdisciplinary nature of IBD management.
  • Assessment of the patient and family burden associated with IBD.

Main Results:

  • Inflammatory bowel diseases require a collaborative approach involving multiple medical disciplines.
  • The management of IBD is complex, necessitating expertise in gastroenterology, immunology, and genetics.
  • Patients and families face considerable emotional, social, and financial challenges due to IBD.

Conclusions:

  • Effective management of inflammatory bowel diseases necessitates integrated care strategies.
  • Further research is needed to alleviate the burden of IBD on patients and families.
  • Understanding the genetic and immunological underpinnings of IBD is crucial for developing novel therapies.

More Related Videos

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...